5- 4- (4- (2- (Amino-2-methoxycarbonylethyl) phenoxy) benzylidene thiazolidine-2,4-dione derivatives and related compounds for reducing plasma glucose, cholesterol and triglyceride levels

摘要

Novel diphenyl ether derivatives are provided that exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance.